Neurofibroma clinical trials

Explore recruiting neurofibroma clinical trials.

Recruiting neurofibroma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neurofibroma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1B, Open-Label Study of Mirdametinib in Infants and Toddlers with Neurofibromatosis Type 1 associated Plexiform Neurofibromas

Spain, Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Neurofibroma trials by city

Neurofibroma in Toronto Neurofibroma in Vancouver Neurofibroma in Montreal Neurofibroma in Calgary Neurofibroma in Edmonton Neurofibroma in Ottawa Neurofibroma in Winnipeg Neurofibroma in Quebec City Neurofibroma in Hamilton Neurofibroma in Kitchener Neurofibroma in London Neurofibroma in Halifax Neurofibroma in New York Neurofibroma in Los Angeles Neurofibroma in Chicago Neurofibroma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease